Clinical Trials: A Phase II Study of Ferumoxytol and Gadolinium Magnetic Resonance Imaging at 3T and 7T in Patients With Malignant Brain Tumors Either Before or After Therapy

Sponsor and Collaborators

Oregon Health and Science University

National Institute of Neurological Disorders and Stroke (NINDS)

Contact

Edward A Neuwelt, MD

503-494-5626     

neuwelte@ohsu.edu

Nancy A Hedrick, BA

503-494-5626

hedrickn@ohsu.edu

Principal Investigator

Edward A Neuwelt, MD, Oregon Health and Science University

ClinicalTrials.gov Identifier

NCT00659126